Zum Inhalt der Seite gehen


Ten die and 100 sent to hospital after taking off-brand Ozempic

Concerns have been raised over the safety of compounded versions of the weight-loss drug, which have not yet been banned by the FDA

Novo Nordisk cited data from the US Food and Drug Administration (FDA) on adverse reactions to compounded versions of semaglutide — the generic name for the drug marketed as Ozempic and Wegovy — since 2023. The reports have not been verified.
#AureFreePress #News #press

https://www.thetimes.com/life-style/health-fitness/article/ozempic-fake-side-effects-weight-loss-gf8djkgws